Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/2b090ae7-2ba0-41e0-9947-3d5d989c2f8e/

METROPOLIS

Metropolis Healthcare Limited
Chart
567.95 INR
Latest Week 2026-07-10
HealthcareDiagnostics & ResearchLARGE
Snapshot 2026-07-12 · 0.6w · Fresh
0.53
OS Score
12.0%
Value
97.0%
Quality
82.0%
Momentum
7/9
F-Score
0.341
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Yes
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 1.00
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
12.0%ile
P/E
62.0×
P/S
7.2×
P/B
7.8×
E/P
0.0223
FCF Yield
0.025
EBITDA/EV
0.035
SH Yield
0.004
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
90.00000000
/100 — 1=cheapest
VC2 (Trending Value)
87.00000000
/100
VC3 (Buyback)
89.00000000
/100
P/E of 62.0x is premium-priced — the market is paying up for expected growth. VC2 score of 87.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
97.0%ile
ROE
0.126
ROA
0.089
Net Margin
0.115
Op Margin
0.162
GPA
0.607
Current
1.40
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.236
Earn Growth
0.310
Stability
0.232
lower=better
Accruals
-0.075
lower=better
5yr Consist
Yes
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
82.0%ile
6M Return
18.5%
12M Return
21.0%
12-1 Mom
13.1%
Risk-Adj
0.46
Vol 252d
28.7%
Vol 60d
66.1%
↑ Expanding
Max DD 12M
-23.4%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (66%) is expanding vs long-term (29%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.53
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 160 peers
Sector Value %ile
25.5%
Sector Quality %ile
94.4%
P/E z-score
-0.11
P/B z-score
0.40
Sector Avg OS
41.5%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 89.0% 80.0% 79.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 95.0% 99.0%
SPARC Sun Pharma Advanced Research Company Limited 96.0% 71.0% 91.0% 94.0%
NATCOPHARM NATCO Pharma Limited 96.0% 86.0% 88.0% 68.0%
AUROPHARMA Aurobindo Pharma Limited 95.0% 73.0% 83.0% 90.0%
STAR Strides Pharma Science Limited 95.0% 75.0% 91.0% 84.0%
LUPIN Lupin Limited 94.0% 64.0% 98.0% 86.0%
SAGILITY Sagility Limited 93.0% 78.0% 87.0% 64.0%
Factor Interactions
Quality Momentum — Expensive
Strong quality (97th) and momentum (82th) but expensive (12th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (97th) but expensive (12th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (66%) significantly exceeds 252-day (29%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
19.4% avg (7 factors)
Quality
B
60.3% avg (7 factors)
Momentum
C
51.1% avg (4 factors)
Risk
B
68.9% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.530—0—
Value %ile0.120—6—
Quality %ile0.970—6—
Momentum %ile0.820—6—
F-Score7.000—6—
Confidence0.920—6—
Volatility0.287—0—
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
61.98
Earnings Yield (E/P)
0.0223
Price / Sales
7.16
Price / Book
7.78
Price / Cash Flow
33.58
FCF Yield
2.5%
EBITDA / EV
3.5%
Sales Yield (1/P·S)
0.1375
Shareholder Yield
Div + net buyback / mktcap
0.4%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
12.6%
Return on Assets
8.9%
Net Margin
11.5%
Operating Margin
16.2%
Gross Profit / Assets
Novy-Marx GPA
60.7%
Current Ratio
1.40
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.075
MomentumPrice trend strength over different horizons
6M Return
18.5%
12M Return
21.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
13.1%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.46
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
23.6%
Earnings Growth (YoY)
31.0%
Earnings Stability (CV)
Lower = more stable
0.232
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
7
Dividend Yield
0.4%
Buyback Yield
-0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
90
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
87
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
89
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity